- Allergic and inflammatory conditions:
- Adults:
- PO 1-2 tabs QID (not to exceed 8 tablets a day)
- 6-12 years:
- PO half a tablet TDS (not to exceed 4 tablets a day)
- PO 2.5mL TDS (max 10mL per day)
- 2-6 years:
- PO 1-2.5mL TDS (max 10mL per day)
- Adults:
Betamethasone 0.25mg
Dexchlorpheniramine maleate 2mg
To be taken at meals and at bedtime.
Betamethasone: glucocorticoid receptor agonist. It controls the biosynthesis of prostaglandins and leukotrienes thereby controlling inflammation.
Dexchlorpheniramine: H1 receptor antagonist. It competes for H1 receptors in blood vessels, respiratory tract and GI tract. It is twice as effective as chlorpheniramine.
- Skin atrophy
- Burning
- Itching
- Allergic contact dermatitis
- Hypertrichosis
- Hypersensitivity to ingredients
- Idiopathic thrombocytopenic purpura
- Infants
- Breastfeeding
- Alcohol
- Antidiabetics
- Amphotericin B
- Aminoglutethimide
- Anticholinesterases
- Antihistamines
Drug Status
| Availability | OTC |
| Pregnancy | Contraindicated due to steroid component |
| Breastfeeding | Contraindicated |
| Schedule | Not controlled |
| BRAND NAME | STRENGTH | FORMULATION | PACK SIZE | MANUFACTURER | DISTRIBUTOR |
|---|---|---|---|---|---|
| Alerset | 0.25mg/2mg | Tablet | 30’s | Centaur Pharma | Sai Pharma |
| Betacor Plus | 0.25mg/2mg | Tablet | 30’s | Twokay Chemicals | Twokay Chemicals |
| Celabet | 0.25mg/2mg | Tablet | 30’s | Win-Pharma Ltd | Win-Pharma Ltd |
| Celabet | 0.25mg/2mg per 5mL | Suspension | 60mL | Win-Pharma Ltd | Win-Pharma Ltd |
| Celestamine | 0.25mg/2mg | Tablet | 30’s | MSD Ltd | Imperial Managed |
| Lestamine | 0.25mg/2mg | Tablet | 30’s | Zawadi Healthcare | Zawadi Healthcare |
| Neugen | 0.25mg/2mg | Tablet | 30’s | Sphinx Pharma | Sphinx Pharma |
| Steramine | 0.25mg/2mg | Tablet | 30’s | Biopharma Ltd | Biopharma Ltd |
| Velestamine | 0.25mg/2mg | Tablet | 30’s | Eastleigh Pharma | Eastleigh Pharma |